Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Poignard

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Nature|April 3, 2009
HIV: Immune memory downloadedDennis R Burton, Pascal Poignard
Journal of Virology|June 20, 2002
Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunizationSara Venturini, Donald E Mosier, Dennis R Burton, et al.
Science (New York, N.Y.)|July 17, 2012
Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse virusesDennis R Burton, Pascal Poignard, Robyn L Stanfield, et al.
European Journal of Immunology|December 3, 2005
Identification of peptides from human pathogens able to cross-activate an HIV-1-gag-specific CD4+ T cell cloneSara Venturini, Gina Allicotti, Yindong Zhao, et al.
Cell Chemical Biology|May 30, 2017
Single-Virus Droplet Microfluidics for High-Throughput Screening of Neutralizing Epitopes on HIV ParticlesChawaree Chaipan, Anna Pryszlak, Hansi Dean, et al.
Emerging Infectious Diseases|August 5, 2021
SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody MonotherapyAurélie Truffot, Julien Andréani, Marion Le Maréchal, et al.
Journal of Virology|December 13, 2002
Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120Ralph Pantophlet, Erica Ollmann Saphire, Pascal Poignard, et al.
Plos One|August 1, 2012
Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2Pascal Poignard, Brian Moldt, Karla Maloveste, et al.
Retrovirology|February 4, 2016
Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodiesStefanie A Krumm, Hajer Mohammed, Khoa M Le, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1Robert Pejchal, Laura M Walker, Robyn L Stanfield, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Nature|April 3, 2009
HIV: Immune memory downloadedDennis R Burton, Pascal Poignard
Journal of Virology|June 20, 2002
Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunizationSara Venturini, Donald E Mosier, Dennis R Burton, et al.
Science (New York, N.Y.)|July 17, 2012
Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse virusesDennis R Burton, Pascal Poignard, Robyn L Stanfield, et al.
European Journal of Immunology|December 3, 2005
Identification of peptides from human pathogens able to cross-activate an HIV-1-gag-specific CD4+ T cell cloneSara Venturini, Gina Allicotti, Yindong Zhao, et al.
Cell Chemical Biology|May 30, 2017
Single-Virus Droplet Microfluidics for High-Throughput Screening of Neutralizing Epitopes on HIV ParticlesChawaree Chaipan, Anna Pryszlak, Hansi Dean, et al.
Emerging Infectious Diseases|August 5, 2021
SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody MonotherapyAurélie Truffot, Julien Andréani, Marion Le Maréchal, et al.
Journal of Virology|December 13, 2002
Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120Ralph Pantophlet, Erica Ollmann Saphire, Pascal Poignard, et al.
Plos One|August 1, 2012
Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2Pascal Poignard, Brian Moldt, Karla Maloveste, et al.
Retrovirology|February 4, 2016
Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodiesStefanie A Krumm, Hajer Mohammed, Khoa M Le, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1Robert Pejchal, Laura M Walker, Robyn L Stanfield, et al.
Pageof 9